IMU

0.00%

4.8¢ imugene limited

" Whilst many posters keep suggesting PH will do a dirty cap...

First 43 Last

Share
Profile

Follow
valueadd

5,956 Posts.

1907

04/07/24

20:31

Post #: 74614827
Share

Originally posted by Taureanbull ↑

Will be worth seeing the next 4c . $112m at 31/3/24 plus $12m R&D rebate still outstanding. Another R &D tax return to be submitted late July. We have no idea why the last one hasn’t been paid yet?.

Looking at the new presentation there seems to be a strong pivot from talking science to highlighting the commercial opportunities.

Whilst many posters keep suggesting PH will do a dirty cap raise, just because he can. That nonsense doesn’t make any sense whatsoever.

Taking a look at our “embarrassment of riches ‘ in the clinical development pipeline the strategy is clearly signposted.

We have 2 programs that are deal ready or very close to deal ready. I’m f IMU were to do a deal with $100m upfront and bigger milestones on a successful registrational trial and again on an FDA Marketing approval, we won’t ever need a cap raise again.

The strategy of doing these ‘expansion trials’ is to get drugs deal ready.

First cab of the rank would be Azer-Cel with results due within a few weeks or months. It’s clearly ready to go.

And I would suggest IMU is fielding considerable interest in VAXINIAs Bilary Cancer FAST TRACK program. It’s primed for a deal when results come in. Probably could be signed by fr now but worth more post results.

Both programs are quick to market with a well defined market size. Just perfect for a hungry Big Pharma.

In fact more then $100 upfront for both of these projects is possible. So why would IMU dilute shareholders capital when they could do deals and still be left with an abundance of opportunities to expand upon.

That is probably why we are seeing Photos in n “X” of a beaming CEO standing at the baggage carousel in Mascot. She knows the level of interest in these programs. And the likely scope and value of any prospective deals.

Monil Shah wants to cement his personal reputation as be a “rainmaker “ and top up his bank account with his bonuses. He would also know exactly what these deals are worth at every stage of development, Because he lives and breathes this stuff 24/7!

Expand

" Whilst many posters keep suggesting PH will do a dirty cap raise, just because he can. That nonsense doesn’t make any sense whatsoever"

It certainly doesn't ....its mainly the utterances of the retired advertising salesman .
Talking with authority like he's got an inside seat at the racing track
...and we all know how that can work out ...... & Who's probably just a bit pissed off coz he's not making ......
the easy bucks trading .
Reminds me of the saying "Empty Vessels make the most noise "

LOL

IMU Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 117 more messages in this thread...

First 43 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change 0.000(0.00%)		Mkt cap ! $356.9M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.8¢	$328.5K	6.792M

Buyers (Bids)

No.	Vol.	Price($)
45	5443565	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	2171910	5

View Market Depth

No.	Vol.	Price($)
45	5443565	0.048
43	4562182	0.047
49	3188200	0.046
61	6392230	0.045
12	2001364	0.044

Price($)	Vol.	No.
0.049	2171910	5
0.050	4756889	17
0.051	6179811	13
0.052	2579418	10
0.053	1158504	8

Last trade - 16.10pm 04/10/2024 (20 minute delay)

IMU (ASX) Chart

" Whilst many posters keep suggesting PH will do a dirty cap...

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

" Whilst many posters keep suggesting PH will do a dirty cap...

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News